Yayınlar & Eserler

Makaleler 2
Tümü (2)
SCI-E, SSCI, AHCI (1)
SCI-E, SSCI, AHCI, ESCI (1)
Scopus (1)
Diğer Yayınlar (1)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 16

1. Examining Classical Cerebro-Spinal Fluid Biomarkers in Primary Progressive Multiple Sclerosis:Implications for Prognosis

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.983-984, (Özet Bildiri) identifier

2. Comparative Analysis of Disease Progression and Disability Accumulation between Early Onset and Adult Onset Multiple Sclerosis Patients at a Decade Post-Diagnosis

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.785, (Özet Bildiri) identifier

3. Prevalence and related factors of restless legs syndrome in pediatric-onset multiple sclerosis

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.770-771, (Özet Bildiri) identifier

4. Determinants of Postpartum Relapse in Multiple Sclerosis: A Comprehensive Analysis of Demographic and Clinical Factors

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, sa.3, ss.196-197, (Özet Bildiri) identifier

5. The Oligoclonal Band Dilemma: Decoding its Role in Predicting Relapsing-Remitting Multiple Sclerosis Progression

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, sa.3, ss.1207, (Özet Bildiri) identifier

6. CXCL13 as a Biomarker for Cognitive Impairment in Multiple Sclerosis: An Investigative Study

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1244-1245, (Özet Bildiri) identifier

7. Does the Association of CXCL13 and CSF Profile in MS Support the Role of CXCL13 as a Potential Prognostic Biomarker?

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Danimarka, 18 - 20 Eylül 2024, cilt.30, ss.1239-1240, (Özet Bildiri) identifier

9. Multipl sklerozlu kişilerde bilişsel yorgunluk ile ilgili faktörler ve sağlıklı kontroller arasındaki farklılıklar

38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, (Yayınlanmadı)

10. Ağır engelli bireylerin demografik ve klinik özellikleri: Türkiye'den tanımlayıcı çalışma

38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Amsterdam, Hollanda, 26 - 28 Ekim 2022, (Yayınlanmadı)

11. BİR MOTOR NÖRON HASTALIĞI NEDENİ KALSİYUM KANALOPATİSİ:OLGU SUNUMU

5.nöromuskuler hastalıklar kongresi, İzmir, Türkiye, 16 - 18 Eylül 2022, ss.1, (Tam Metin Bildiri) Sürdürülebilir Kalkınma
Metrikler

Yayın

18

Yayın (WoS)

8

Yayın (Scopus)

1

Atıf (Sobiad)

1

H-İndeks (Sobiad)

1
BM Sürdürülebilir Kalkınma Amaçları